Pharmaceutical Drying Equipment Market: Growth, Size, Share, and Trends

Report Code PH 2704
Published in Oct, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Pharmaceutical Drying Equipment Market by Type (Freeze, Spray, Vacuum, Fluidized Bed), Scale of Operation (Industrial-scale, Pilot-scale, Lab-scale), End User (Pharmaceutical Companies, CDMOs, Research Universities) - Global Forecast to 2029

Overview

The global pharmaceutical drying equipment market is projected to reach USD 8.18 billion by 2029 from USD 5.80 billion in 2024, at a CAGR of 7.1% during the forecast period. The expansion of pharmaceutical manufacturing facilities globally, increased demand for biopharmaceuticals such as vaccines, antibodies, and hormones, and the rapid growth of CMOs drive market growth. The market has grown considerably due to the expansion of pharmaceutical manufacturing facilities and the rapid development of CMOs and CDMOs. At the same time, the rising competition in pharmaceutical manufacturing companies due to the loss of various drug’s market exclusivity will pose an opportunity to the market.

Attractive Opportunities in the Pharmaceutical Drying Equipment Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to the rising prevalence of chronic diseases and increasing demand for pharmaceutical and biopharmaceutical medications.

The growth of Asia- Pacific market can be attributed to the expansion of pharmaceutical manufacturing facilities, increased demand for biopharmaceuticals, rapid growth of CMOs.

Increasing competition in pharmaceutical manufacturing industry due to the loss of market exclusivity of various drugs and high the high growth potential of emerging markets are likely to promote significant market growth opportunity of the market

The Asia- Pacific Market is projected to reach 3.05 billion by 2029, at the highest CAGR of 8.4% during the forecast period.

The Asia Pacific is the largest regional market for pharmaceutical drying equipment, with a share of 34.6% due to the increasing investment by key players in the region

Global Pharmaceutical Drying Equipment Market Dynamics

DRIVER: Increasing expansion of pharmaceutical manufacturing facilities

The market for pharmaceutical drying equipment is expanding due to the growing number of pharmaceutical manufacturing facilities opening up worldwide. The need for pharmaceuticals is rising in tandem with the frequency of chronic diseases. The incidence and prevalence of chronic diseases have been on the rise globally. As a result, pharmaceutical manufacturing facilities have expanded their operations and created new facilities due to the rising demand. In March 2023, Takeda Pharmaceuticals invested in a new plasma-derived therapy production facility in Japan for 100 billion Yen (USD 0.75 billion). Also, in July 2024, BeiGene commenced its clinical R&D center and biologics manufacturing facility in the US. Thus, innovative pharmaceutical drying equipment is required for these expansions to process APIs effectively and preserve product quality. The pharmaceutical industry needs drying equipment that can handle different formulations without compromising quality as they concentrate on creating novel medicines and improving manufacturing efficiency. Consequently, the market for pharmaceutical drying equipment has expanded and is also projected to grow due to the increasing number of facilities alongside the development of the existing manufacturing processes.

RESTRAINT: Demand for refurbished drying equipment

The increasing demand for reconditioned drying equipment has restrained the pharmaceutical drying equipment market. Many pharmaceutical businesses have replaced their expensive machinery with refurbished options as a more cost-effective way to reconcile cost-efficiency and operational requirements. Refurbished drying equipment presents an alternative for companies looking to reduce expenses; this is particularly valid for new businesses or companies based in emerging economies. This trend toward adopting refurbished solutions instead of new machinery may cause the market for new pharmaceutical drying equipment to slow down dramatically, as manufacturers may prioritize cost concerns above technological advancements. However, refurbished drying equipment does not constantly have updated operational formats, which affects the drying technique, offering a risk to product quality. The increase in the use of refurbished equipment might further be sustained. At the same time, organizations weigh the potential of cost efficiencies achieved by employing standards against emerging the choice of using new technology developments and those created by compliance demands of regulations; this proves to be quite tasking, especially for producers of new drying solutions. Therefore, this shift towards used equipment is a significant challenge to future market growth.

 

OPPORTUNITY: Increasing focus on personalized medicine

The increasing competition in the pharmaceutical manufacturing industry has increased due to loss of market exclusivity for various drugs. The key patents are expiring, and new generic and biosimilar products are expected to enter the market. For instance, the patents of drugs such as GSK's Dolutegravir (2027–2029), Bristol Myers Squibb's Revlimid (2025–2026), and Merck & Co.'s KEYTRUDA (2028) are all scheduled to expire. Due to this loss of exclusivity in coming years, producers of biosimilars and generics will have to increase their production capacity to gain market share in this competitive climate. Thus, many companies have aimed to expand their manufacturing facilities and capture the market. For instance, Sandoz, a well-known global producer of generic and biosimilar drugs, plans to invest at least USD 400 million in a new biologics facility in Slovenia; its operations will commence in late 2026. The demand for pharmaceutical drying equipment will rise due to this development in manufacturing capacity. These new facilities will need to use cutting-edge drying technologies to guarantee the effectiveness and caliber of their production processes. Consequently, the market for pharmaceutical drying equipment has expanded due to competition from drug patents that are about to expire.

CHALLENGES: Higher maintenance of the pharmaceutical drying equipment

The higher maintenance required is a significant challenge for the market's growth for pharmaceutical drying equipment. For drying equipment to operate well, it must be calibrated and maintained correctly. Ineffective drying operations can result from inadequate maintenance. Thus, the operation cost increases, and the quality of pharmaceutical products is lowered; this impacts the equipment's overall performance and longevity. Ill-maintained equipment also does not provide the company with genuine effects for their products, hampering market growth. The pharmaceutical industry has maintained strict regulations for companies for their pharmaceutical drying equipment, and failure to comply with these regulations can hamper the product’s quality and efficacy, making adequate maintenance one of the prime focuses. However, manufacturers may find it challenging to bear routine maintenance expenses. As this equipment is costly, it needs efficient maintenance and calibration. These continuous maintenance needs can burden resources and reduce profitability for many businesses, notably smaller or medium-sized firms. As a result, the difficulty of overseeing high maintenance requirements may discourage investment in new drying machinery and impede the market's overall expansion for pharmaceutical drying machinery.

Global Pharmaceutical Drying Equipment Market Ecosystem Analysis

The ecosystem of the pharmaceutical drying equipment market comprises elements present in this market, and these elements are defined with a demonstration of the bodies involved. It includes manufacturers, distributors, research & product developers, and end users. The ecosystem of the overall Pharmaceutical drying equipment market comprises the different elements and subdivisions present in it. Manufacturers include the organizations involved in research, product development, optimization, and launch. Distributors include third parties and eCommerce sites linked with organizations for marketing freeze dryers, spray dryers, fluid bed dryers, and vacuum dryers. Research and product development includes in-house research facilities organizations, contract research organizations, and contract development and manufacturing organizations, which play a crucial role in outsourcing research for product development to manufacturers.

 

By type, freeze dryers segment to possess highest CAGR during forecast period

Based on type, the freeze dryers segment is the fastest growing due to the rising demand for biopharmaceuticals, which include antibiotics, hormones, and vaccinations. Heat-sensitive products are preserved via freeze-drying, also known as lyophilization, which eliminates moisture without compromising the efficacy and stability of active medicinal components. This process is crucial since it significantly reduces logistical issues for biopharmaceuticals that must be kept for lengthy periods without a cold chain. Freeze drying ensures that the biopharmaceutical quality is not compromised during transportation and can reach the end user consistently. Also, medical professionals find them incredibly convenient because freeze-dried goods such as vaccinations and antibiotics may be rapidly reconstituted in water or saline solution at the treatment site. This technology is increasingly needed because over half of the biopharmaceutical products listed by the USFDA and EMA are freeze-dried. Additionally, freeze dryers maintain product stability by lowering biological activity, which enables medications to maintain their effectiveness for longer. Their role in maintaining product integrity during storage and transportation drives freeze dryers as a key pharmaceutical drying equipment market segment.

By end user, pharmaceutical and biotech companies hold the largest market share

Based on the end user, the pharmaceutical drying equipment market has been classified into pharmaceutical and biotech companies, contract development and manufacturing organizations (CDMOs), and research academies and universities. The market was dominated in 2023 by pharmaceutical and biotech companies, while CDMOs registered the highest growth rate.

Pharmaceutical and biotech companies hold the largest share in the pharmaceutical drying equipment market, owing to the increased expansion of manufacturing facilities to meet the rising global demand for medication. This rising expansion is due to the increasing prevalence of various chronic diseases such as cancer, diabetes, and cardiovascular diseases. These dryers are necessary during the manufacturing process of different pharmaceutical and biotech companies, such as hormones, vaccines, and active pharmaceutical ingredients (APIs). Additionally, these dryers ensure the stability and quality of the products. To maximize production and scale up operations effectively, pharmaceutical and biotech companies heavily invest in cutting-edge drying equipment like freeze dryers as novel medicines, particularly biopharmaceuticals like vaccines, antibodies, and hormones, continue to be created. Moreover, the pharmaceutical industry's rising outsourcing of manufacturing processes drives the fastest growth in the CDMOs segment. Pharmaceutical businesses are increasingly depending on CDMOs to handle manufacturing as they look to cut expenses and concentrate on their primary R&D activities.

Asia Pacific segment to be fastest growing market segment from 2024 to 2029

The Asia Pacific segment is the fastest growing region in the pharmaceutical drying equipment market due to the rapid expansion of pharmaceutical and biopharmaceutical companies across significant countries such as China, India, and Japan. China is the central hub for active pharmaceutical ingredient manufacturing, thus playing an essential role in driving demand for pharmaceutical drying equipment. In addition, numerous market participants in Japan, including Yamato Scientific Co., Ltd., Hosokawa Micron Group, and Freund Corporation, propel the Asia Pacific market growth. These businesses are focused on technological advancements, which, in turn, also aid market growth. India's cost advantages, highly skilled labor pool, and improved regulatory climate make it a more appealing destination for domestic and international pharmaceutical companies. Consequently, the nation's pharmaceutical business has also expanded rapidly. India's growing stature in the world economy drives up demand for pharmaceutical drying equipment. The need for advanced drying technologies to ensure product quality and compliance grows as pharmaceutical manufacturing in the Asia Pacific region continues to rise, driven by cost efficiencies, increasing production capacities, and government support; this solidifies Asia Pacific's position as the fastest-growing segment in the market.

HIGHEST CAGR MARKET IN 2023
ASIA PACIFIC FASTEST GROWING MARKET IN THE REGION

Recent Developments of Pharmaceutical Drying Equipment Market

  • Expansion: On June 7, 2024, Syntegon expanded its pharmaceutical processing and packaging business by acquiring Azbil Telstar, previously a subsidiary of Japan's Azbil Corporation.
  • Rebrand: In February 2023, SP Industries, Inc. ("Scientific Products"), a leading global provider of fill-finish drug manufacturing solutions, lyophilizers, and laboratory equipment and supplies, rebranded and began operating under the name ATS Life Sciences Scientific Products.
  • Investment: In September 2022, GEA invested EUR 70 million to build a new pharmaceutical technology center for freeze dryers in Elsdorf, North Rhine-Westphalia, Germany.
  • Agreement: In November 2021, ATS Automation Tooling Systems Inc., a leading automation solutions provider, announced that it had signed a definitive agreement to acquire SP Industries, Inc. for USD 445 million.

Key Market Players

KEY PLAYERS IN THE PHARMACEUTICAL DRYING EQUIPMENT MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Pharmaceutical Drying Equipment Market?

Scope of the Report

Report Metric Details
Market size available for years 2024-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million/Billion)
Segments covered Type, Scale of Operation, End User, and Region
Geographies covered North America (US & Canada), Europe (Germany, UK, France, Italy, Spain, and RoE), APAC (Japan, China, Australia, South Korea, India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA (GCC Countries, RoMEA)

 

Key Questions Addressed by the Report

What are the drivers of the pharmaceutical drying equipment market?
The pharmaceutical drying equipment market drivers include expanding pharmaceutical manufacturing facilities to drive market growth, increased demand for biopharmaceuticals, and rapid development of CMOs and CDMOs to drive the market.
Which type of dryer dominates the pharmaceutical drying equipment market?
The freeze dryer segment dominates the pharmaceutical drying equipment market.
Who are the end users of the pharmaceutical drying equipment? Which end user is leading the market?
The pharmaceutical drying equipment market is segmented into pharmaceutical & biotech companies, contract development and manufacturing organizations, and research academics and universities. The pharmaceutical and biotech companies segment had the largest pharmaceutical drying equipment market share in 2023.
Who are the key players in the pharmaceutical drying equipment market?
The key players in the pharmaceutical drying equipment market are GEA Group (Germany), ATS Corporation (US), Hosokawa Micron Group (Japan), Freund Corporation (Japan), IMA Industria Macchine Automatiche SPA (Italy), Syntegon Technology GmbH (Germany), BUCHI Labortechnik AG (Switzerland), OPTIMA (Germany), MechaTech Systems Ltd (Netherland), and BEW Engineering (India).
Which region is lucrative for the pharmaceutical drying equipment market?
The Asia Pacific market is expected to witness the highest growth rate during the forecast period.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Drying Equipment Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
23
RESEARCH METHODOLOGY
28
EXECUTIVE SUMMARY
40
PREMIUM INSIGHTS
43
MARKET OVERVIEW
47
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Expansion of pharmaceutical manufacturing facilities
    - High demand for biopharmaceuticals
    - Rapid growth of contract manufacturing and development companies
    RESTRAINTS
    - Increased demand for refurbished drying equipment
    OPPORTUNITIES
    - Increased market competition and high demand for generic and biosimilar drugs
    - High growth potential in emerging economies
    CHALLENGES
    - Need for regular maintenance and high associated costs
  • 5.3 INDUSTRY TRENDS
    AUTOMATION AND DIGITALIZATION
    ENVIRONMENTAL SUSTAINABILITY
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Automation and control systems
    - Heat transfer technology
    - Vacuum technology
    COMPLEMENTARY TECHNOLOGIES
    - High-efficiency particulate air (HEPA) filtration technology
    - Temperature control systems
    - Desorption technology
    ADJACENT TECHNOLOGIES
    - Moisture sensors and monitoring systems
    - Air distribution systems
    - Particle size analysis technology
  • 5.5 PORTER’S FIVE FORCE ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.7 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East & Africa
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.9 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 8419
    EXPORT DATA FOR HS CODE 8419
  • 5.10 PRICING ANALYSIS
    INDICATIVE SELLING PRICE OF DRYERS, BY PRODUCT
    INDICATIVE SELLING PRICE OF DRYERS, BY REGION
  • 5.11 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.12 UNMET NEEDS
  • 5.13 END-USER EXPECTATIONS
  • 5.14 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL DRYING EQUIPMENT MARKET
    KEY USE CASES
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    CASE STUDY 1: IMPROVED VACUUM PRESSURE TO REDUCE DRYING TIME, INCREASE QUALITY, AND SAVE PRODUCTION COSTS
    CASE STUDY 2: OPTIMIZED PARTICLE SIZE DISTRIBUTION FOR HIGH-POTENCY API PRODUCTION
    CASE STUDY 3: INNOVATIVE CONTAINMENT SOLUTIONS FOR HIGH-POTENCY APIS TO ENHANCE NUTSCHE FILTER DRYER PERFORMANCE
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 ADJACENT MARKET ANALYSIS
    SPRAY DRYING EQUIPMENT MARKET
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.20 INVESTMENT AND FUNDING SCENARIO
PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE
79
  • 6.1 INTRODUCTION
  • 6.2 SPRAY DRYERS
    ABILITY TO MAINTAIN STABILITY OF THERMALLY SENSITIVE COMPOUNDS THROUGH RAPID DRYING TO PRESERVE DRUG EFFICACY
  • 6.3 FREEZE DRYERS
    RISING DEMAND FOR LYOPHILIZED PRODUCTS TO DRIVE MARKET
  • 6.4 FLUIDIZED BED DRYERS
    COST-EFFECTIVENESS AND UNIFORM DRYING TO SPUR DEMAND IN PHARMACEUTICAL MANUFACTURING FACILITIES
  • 6.5 VACUUM DRYERS
    VACUUM DRYERS TO MINIMIZE THERMAL DEGRADATION AND PROVIDE STABILITY TO HEAT-SENSITIVE MATERIALS
  • 6.6 OTHER DRYERS
PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION
90
  • 7.1 INTRODUCTION
  • 7.2 INDUSTRIAL-SCALE EQUIPMENT
    RISING INVESTMENTS IN HIGH-QUALITY MANUFACTURING TO AUGMENT MARKET GROWTH
  • 7.3 PILOT-SCALE EQUIPMENT
    INCREASED PHARMACEUTICAL R&D INVESTMENTS AND FOCUS ON EFFECTIVE QUALITY CONTROL IN LARGER OPERATIONS TO DRIVE MARKET
  • 7.4 LABORATORY-SCALE EQUIPMENT
    COST-EFFECTIVENESS, EASY OPERATION, AND LOW MAINTENANCE NEEDS TO FUEL MARKET GROWTH
PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER
95
  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL AND BIOTECH COMPANIES
    INCREASED INVESTMENTS FOR BETTER PRODUCTION EFFICIENCY IN PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
  • 8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
    INCREASED OUTSOURCING OF RESEARCH AND MANUFACTURING PROCESSES BY PHARMA COMPANIES TO PROPEL MARKET GROWTH
  • 8.4 RESEARCH ACADEMIES AND UNIVERSITIES
    RISING DEMAND FOR ADVANCED LABORATORY AND RESEARCH FACILITIES IN ACADEMIC SETTINGS TO DRIVE MARKET
PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION
100
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American pharmaceutical drying equipment market during forecast period
    CANADA
    - Robust pharmaceutical sector and advancements in drug development to aid market growth
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increased R&D investments by key players and technological advancements to support market growth
    FRANCE
    - Rising investments in bioproduction capacities to spur market growth
    ITALY
    - Growing demand for biologics and biopharmaceuticals to boost market growth
    UK
    - Increased government investments in pharmaceuticals and clinical trials to propel market growth
    SPAIN
    - Increasing collaborations between drying equipment manufacturing companies to aid market growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Technological advancements and strategic expansions by key international players to augment market growth
    JAPAN
    - High investments in manufacturing capabilities and increased geriatric population to aid market growth
    INDIA
    - Increasing investments in manufacturing facilities to propel market growth
    AUSTRALIA
    - Rising demand for pharmaceuticals and increasing advancements in drug formulations to drive market
    SOUTH KOREA
    - Increased popularity of CDMOs for pharmaceutical production to fuel market growth
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Advanced biologics sector and increased demand for biosimilars to drive market
    MEXICO
    - Burgeoning pharmaceutical industry and favorable trade agreements to propel market growth
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Expansion of pharmaceutical manufacturing companies to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
156
  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
  • 10.3 REVENUE ANALYSIS, 2021–2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Type footprint
    - Scale of operation footprint
    - End-user footprint
    - Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 COMPANY VALUATION AND FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
174
  • 11.1 KEY PLAYERS
    GEA GROUP AKTIENGESELLSCHAFT
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA
    - Business overview
    - Products offered
    - MnM view
    ATS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    HOSOKAWA MICRON GROUP
    - Business overview
    - Products offered
    - MnM view
    FREUND CORP.
    - Business overview
    - Products offered
    SYNTEGON TECHNOLOGY GMBH
    - Business overview
    - Products offered
    - Recent developments
    BÜCHI LABORTECHNIK AG
    - Business overview
    - Products offered
    - Recent developments
    OPTIMA
    - Business overview
    - Products offered
    MECHATECH SYSTEMS LTD.
    - Business overview
    - Products offered
    BEW ENGINEERING
    - Business overview
    - Products offered
  • 11.2 OTHER PLAYERS
    ZIRBUS TECHNOLOGY GMBH
    SPX FLOW, INC.
    EUROPEAN SPRAYDRY TECHNOLOGIES
    YAMATO SCIENTIFIC CO., LTD.
    SAKA
    ILSHIN BIOBASE
    OKAWARA MFG. CO., LTD.
    CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.
    BACHILLER
    MILLROCK TECHNOLOGY, INC.
    MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH
    LABCONCO
    O’HARA TECHNOLOGIES
    COOLVACUUM TECHNOLOGIES, SL
    SHACHI ENGINEERING PVT. LTD.
APPENDIX
218
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 PHARMACEUTICAL DRYING EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 CURRENCY CONVERSION RATES
  • TABLE 3 PHARMACEUTICAL DRYING EQUIPMENT MARKET: STUDY ASSUMPTIONS
  • TABLE 4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: RISK ASSESSMENT
  • TABLE 5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PORTER’S FIVE FORCES
  • TABLE 6 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL DRYING EQUIPMENT
  • TABLE 7 KEY BUYING CRITERIA FOR PHARMACEUTICAL DRYING EQUIPMENT
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 LIST OF PATENTS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET, 2014−2024
  • TABLE 14 IMPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018–2023 (USD MILLION)
  • TABLE 15 EXPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018–2023 (USD MILLION)
  • TABLE 16 INDICATIVE SELLING PRICING OF DRYERS, 2021–2023
  • TABLE 17 INDICATIVE SELLING PRICE OF DRYERS, BY REGION, 2022–2024
  • TABLE 18 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
  • TABLE 19 PHARMACEUTICAL DRYING EQUIPMENT MARKET: UNMET NEEDS
  • TABLE 20 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER EXPECTATIONS
  • TABLE 21 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 22 SPRAY DRYERS OFFERED BY KEY PLAYERS
  • TABLE 23 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR SPRAY DRYERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 24 FREEZE DRYERS OFFERED BY KEY PLAYERS
  • TABLE 25 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FREEZE DRYERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 FLUIDIZED BED DRYERS OFFERED BY KEY PLAYERS
  • TABLE 27 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FLUIDIZED BED DRYERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 VACUUM DRYERS OFFERED BY KEY PLAYERS
  • TABLE 29 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR VACUUM DRYERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR OTHER DRYERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 OTHER DRYERS OFFERED BY KEY PLAYERS
  • TABLE 32 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 33 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR INDUSTRIAL-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PILOT-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR LABORATORY-SCALE EQUIPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 37 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR RESEARCH ACADEMIES AND UNIVERSITIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 41 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 43 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 45 US: KEY MACROINDICATORS
  • TABLE 46 US: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 47 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 48 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 49 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 50 CANADA: KEY MACROINDICATORS
  • TABLE 51 CANADA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 52 TOP FIVE EXPORTERS OF PHARMACEUTICAL PRODUCTS TO CANADA
  • TABLE 53 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 54 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 55 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 56 EUROPE: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 57 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 59 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 60 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 61 GERMANY: KEY MACROINDICATORS
  • TABLE 62 GERMANY: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 63 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 64 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 65 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 66 FRANCE: KEY MACROINDICATORS
  • TABLE 67 FRANCE: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 68 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 69 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 70 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 71 ITALY: KEY MACROINDICATORS
  • TABLE 72 ITALY: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 73 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 74 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 75 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 76 UK: KEY MACROINDICATORS
  • TABLE 77 UK: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 78 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 79 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 80 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 81 SPAIN: KEY MACROINDICATORS
  • TABLE 82 SPAIN: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 83 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 85 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 86 SWITZERLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 87 POLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 88 BELGIUM: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION)
  • TABLE 89 AUSTRIA: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION)
  • TABLE 90 IRELAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 91 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 93 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 98 CHINA: KEY MACROINDICATORS
  • TABLE 99 CHINA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 100 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 102 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 103 JAPAN: KEY MACROINDICATORS
  • TABLE 104 JAPAN: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 105 JAPAN: PHARMACEUTICAL PRODUCTION, BY DOSAGE FORM
  • TABLE 106 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 108 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 109 INDIA: KEY MACROINDICATORS
  • TABLE 110 INDIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 111 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 113 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 114 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 115 AUSTRALIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 116 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 118 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 119 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 120 SOUTH KOREA: PHARMACEUTICAL MANUFACTURERS SIZE
  • TABLE 121 SOUTH KOREA: PHARMACEUTICAL PRODUCTION VALUE (USD BILLION)
  • TABLE 122 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 124 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 125 SINGAPORE: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 126 SINGAPORE: PHARMACEUTICAL AND BIOLOGICAL PRODUCTION INDEX (2019–2023)
  • TABLE 127 MALAYSIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 128 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 130 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 131 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 134 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 135 BRAZIL: KEY MACROINDICATORS
  • TABLE 136 BRAZIL: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 137 BRAZIL: IMPORT VALUE OF PHARMACEUTICAL PRODUCTS (2020–2023)
  • TABLE 138 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 140 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 141 MEXICO: KEY MACROINDICATORS
  • TABLE 142 MEXICO: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 143 MEXICO: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE (2020–2023)
  • TABLE 144 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 146 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 147 ARGENTINA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 148 ARGENTINA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 149 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 151 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 153 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 156 UAE: GROWTH RATE OF PHARMACEUTICAL MANUFACTURING PLANT, 2010 VS. 2021
  • TABLE 157 SAUDI ARABIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 158 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 160 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 161 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 162 SOUTH AFRICA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 163 EGYPT: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 164 GHANA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 165 KENYA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 166 ETHIOPIA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 167 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 168 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)
  • TABLE 169 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 170 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
  • TABLE 171 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEGREE OF COMPETITION
  • TABLE 172 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TYPE FOOTPRINT
  • TABLE 173 PHARMACEUTICAL DRYING EQUIPMENT MARKET: SCALE OF OPERATION FOOTPRINT
  • TABLE 174 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER FOOTPRINT
  • TABLE 175 PHARMACEUTICAL DRYING EQUIPMENT MARKET: REGION FOOTPRINT
  • TABLE 176 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYER
  • TABLE 177 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 178 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 179 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 180 PHARMACEUTICAL DRYING EQUIPMENT MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 181 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
  • TABLE 182 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS OFFERED
  • TABLE 183 GEA GROUP AKTIENGESELLSCHAFT: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 184 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: COMPANY OVERVIEW
  • TABLE 185 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCTS OFFERED
  • TABLE 186 ATS CORPORATION: COMPANY OVERVIEW
  • TABLE 187 ATS CORPORATION: PRODUCTS OFFERED
  • TABLE 188 ATS CORPORATION PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 189 ATS CORPORATION: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 190 ATS CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 191 HOSOKAWA MICRON GROUP: COMPANY OVERVIEW
  • TABLE 192 HOSOKAWA MICRON GROUP: PRODUCTS OFFERED
  • TABLE 193 FREUND CORP.: COMPANY OVERVIEW
  • TABLE 194 FREUND CORP.: PRODUCTS OFFERED
  • TABLE 195 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
  • TABLE 196 SYNTEGON TECHNOLOGY GMBH: PRODUCTS OFFERED
  • TABLE 197 SYNTEGON TECHNOLOGY GMBH: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 198 BÜCHI LABORTECHNIK AG.: COMPANY OVERVIEW
  • TABLE 199 BÜCHI LABORTECHNIK AG: PRODUCTS OFFERED
  • TABLE 200 BÜCHI LABORTECHNIK AG: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 201 OPTIMA: COMPANY OVERVIEW
  • TABLE 202 OPTIMA: PRODUCTS OFFERED
  • TABLE 203 MECHATECH SYSTEMS LTD.: COMPANY OVERVIEW
  • TABLE 204 MECHATECH SYSTEMS LTD.: PRODUCTS OFFERED
  • TABLE 205 BEW ENGINEERING: COMPANY OVERVIEW
  • TABLE 206 BEW ENGINEERING: PRODUCTS OFFERED
  • TABLE 207 ZIRBUS TECHNOLOGY GMBH: COMPANY OVERVIEW
  • TABLE 208 SPX FLOW, INC.: COMPANY OVERVIEW
  • TABLE 209 EUROPEAN SPRAYDRY TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 210 YAMATO SCIENTIFIC CO., LTD.: COMPANY OVERVIEW
  • TABLE 211 SAKA: COMPANY OVERVIEW
  • TABLE 212 ILSHIN BIOBASE: COMPANY OVERVIEW
  • TABLE 213 OKAWARA MFG. CO., LTD.: COMPANY OVERVIEW
  • TABLE 214 CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.: COMPANY OVERVIEW
  • TABLE 215 BACHILLER: COMPANY OVERVIEW
  • TABLE 216 MILLROCK TECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 217 MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH: COMPANY OVERVIEW
  • TABLE 218 LABCONCO: COMPANY OVERVIEW
  • TABLE 219 O’HARA TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 220 COOLVACUUM TECHNOLOGIES, SL: COMPANY OVERVIEW
  • TABLE 221 SHACHI ENGINEERING PVT. LTD.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 PHARMACEUTICAL DRYING EQUIPMENT MARKET: SEGMENTS AND REGIONS COVERED
  • FIGURE 2 PHARMACEUTICAL DRYING EQUIPMENT MARKET: YEARS CONSIDERED
  • FIGURE 3 PHARMACEUTICAL DRYING EQUIPMENT MARKET: RESEARCH DESIGN
  • FIGURE 4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PRIMARY SOURCES
  • FIGURE 6 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY DATA FROM PRIMARIES
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 9 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TOP-DOWN APPROACH
  • FIGURE 10 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
  • FIGURE 11 IMPACT OF CAGR ON DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029)
  • FIGURE 12 PHARMACEUTICAL DRYING EQUIPMENT MARKET: CAGR PROJECTIONS
  • FIGURE 13 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DATA TRIANGULATION
  • FIGURE 14 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 PHARMACEUTICAL DRYING EQUIPMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • FIGURE 18 RISING INVESTMENT BY PHARMACEUTICAL FACILITIES TO DRIVE MARKET
  • FIGURE 19 PHARMACEUTICAL AND BIOTECH COMPANIES COMMANDED LARGEST MARKET SHARE IN 2023
  • FIGURE 20 INDIA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 21 ASIA PACIFIC TO GROW AT HIGHEST GROWTH RATE FROM 2024 TO 2029
  • FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 23 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL DRYING EQUIPMENT
  • FIGURE 26 KEY BUYING CRITERIA FOR PHARMACEUTICAL DRYING EQUIPMENT
  • FIGURE 27 NUMBER OF PATENTS PUBLISHED (JANUARY 2014–AUGUST 2024)
  • FIGURE 28 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR PHARMACEUTICAL DRYING EQUIPMENT PATENTS (JANUARY 2014−AUGUST 2024)
  • FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR PHARMACEUTICAL DRYING EQUIPMENT (JANUARY 2014−JULY 2024)
  • FIGURE 30 AVERAGE SELLING PRICE OF SINGLE-LIMB BREATHING CIRCUITS (2024)
  • FIGURE 31 MARKET POTENTIAL OF AI TO ENHANCE EFFICACY AND PRODUCT QUALITY
  • FIGURE 32 PHARMACEUTICAL DRYING EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 33 PHARMACEUTICAL DRYING EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 34 SPRAY DRYING EQUIPMENT: MARKET OVERVIEW
  • FIGURE 35 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 36 PHARMACEUTICAL DRYING EQUIPMENT MARKET: INVESTMENT AND FUNDING SCENARIO (2020–2023)
  • FIGURE 37 PHARMACEUTICAL DRYING EQUIPMENT MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 38 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS (2021–2023)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
  • FIGURE 42 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 43 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPANY FOOTPRINT
  • FIGURE 44 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 PHARMACEUTICAL DRYING EQUIPMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 48 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT
  • FIGURE 49 ATS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 50 HOSOKAWA MICRON GROUP: COMPANY SNAPSHOT
  • FIGURE 51 FREUND CORP.: COMPANY SNAPSHOT
  • FIGURE 52 BEW ENGINEERING: COMPANY SNAPSHOT

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study , International Diabetes Federation (IDF), and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global pharmaceutical drying equipment market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the pharmaceutical drying equipment market. The primary sources from the demand side include pharmaceutical, biopharmaceutical companies, contract development and manufacturing organizations, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global pharmaceutical drying equipment market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global pharmaceutical drying equipment market was split into various segments and sub-segments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of various pharmaceutical drying equipment manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from pain management devices(or the nearest reported business unit/product category)
  • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom Up approach & Top down approach)

Data Triangulation

After arriving at the overall size of the global pharmaceutical drying equipment market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Pharmaceutical drying equipment is used to remove solvents, such as water, from drug formulations through the application of heat. This process ensures the stability and efficacy of the final product by preventing chemical and microbiological deterioration. Common methods include air drying, vacuum drying, freeze-drying, and spray drying. These methods are crucial in both research and large-scale manufacturing to produce dry solid masses or powders, maintaining the quality and safety of active pharmaceutical ingredients (APIs).

Stakeholders

  • Pharmaceutical drying equipment Manufacturers
  • Freeze-drying/lyophilization equipment vendors/service providers
  • Research and consulting firms
  • Venture capitalists
  • Government agencies
  • Raw material suppliers
  • Regulatory bodies
  • Commercial research & development (R&D) institutions and financial institutions
  • Importers and exporters of pharmaceutical drying equipment
  • Traders, distributors, and suppliers
  • Government and research organizations
  • Trade associations and industry bodies

Report Objectives

  • To define, describe, and forecast the pharmaceutical drying equipment market based on type, scale of operation, end user, and region.
  • To forecast the market size based on five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events.
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall pharmaceutical drying equipment market.
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically profile key players in the pharmaceutical drying equipment market and comprehensively analyze their core competencies.
  • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall pharmaceutical drying equipment market.
  • To benchmark players within the market using the proprietary “Competitive Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
  • To analyze the generative AI  impact on the pharmaceutical drying equipment market

Previous Versions of this Report

Freeze Drying Market / Lyophilization Market by Type (Tray, Shell, Manifold), Scale of operation (Industrial, Lab, Pilot), Application (Food, Pharma & Biotech), Accessories (Loading & Unloading, Monitoring, Vacuum Systems, Drying Chambers) - Global Forecast to 2025

Report Code PH 2704
Published in Oct, 2024, By MarketsandMarkets™

Freeze-Drying/Lyophilization Market by Type (Tray, Shell, Manifold), Scale of operation (Industrial, Lab, Pilot), Application (Food, Pharma & Biotech), Accessories (Loading & Unloading, Monitoring, Vacuum Systems, Drying Chambers) - Global Forecast to 2025

Report Code PH 2704
Published in Oct, 2020, By MarketsandMarkets™

Freeze-Drying/Lyophilization Market by Type (Tray, Shell, Manifold), Scale of operation (Industrial, Lab, Pilot), Application (Food, Pharma & Biotech), Accessories (Loading & Unloading, Monitoring, Vacuum Systems, Drying Chambers) - Global Forecast to 2025

Report Code PH 2704
Published in Sep, 2014, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Pharmaceutical Drying Equipment Market

DMCA.com Protection Status